loadpatents
name:-0.015010118484497
name:-0.01729416847229
name:-0.0066308975219727
Eng; Wai-Si Patent Filings

Eng; Wai-Si

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eng; Wai-Si.The latest application filed is for "compounds as neurokinin-1 receptor antagonists and uses thereof".

Company Profile
5.12.12
  • Eng; Wai-Si - Maple Glen PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ketamine derivatives and compositions thereof
Grant 11,440,874 - Xiang , et al. September 13, 2
2022-09-13
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
Grant 11,420,955 - Xiang , et al. August 23, 2
2022-08-23
Compounds As Neurokinin-1 Receptor Antagonists And Uses Thereof
App 20220002246 - XIANG; JIA-NING ;   et al.
2022-01-06
Compounds as neurokinin-1 receptor antagonists and uses thereof
Grant 11,149,006 - Xiang , et al. October 19, 2
2021-10-19
Compounds As Neuronal Histamine Receptor-3 Antagonists And Uses Thereof
App 20210188808 - XIANG; JIA-NING ;   et al.
2021-06-24
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
Grant 10,968,202 - Xiang , et al. April 6, 2
2021-04-06
Ketamine Derivatives And Compositions Thereof
App 20210032199 - XIANG; JIA-NING ;   et al.
2021-02-04
Compounds As Neuronal Histamine Receptor-3 Antagonists And Uses Thereof
App 20200369645 - XIANG; JIA-NING ;   et al.
2020-11-26
Ketamine derivatives and compositions thereof
Grant 10,836,714 - Xiang , et al. November 17, 2
2020-11-17
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
Grant 10,730,853 - Xiang , et al.
2020-08-04
Compounds As Neurokinin-1 Receptor Antagonists And Uses Thereof
App 20200239416 - XIANG; JIA-NING ;   et al.
2020-07-30
Ketamine Derivatives And Compositions Thereof
App 20200231540 - XIANG; JIA-NING ;   et al.
2020-07-23
Ketamine derivatives and compositions thereof
Grant 10,683,262 - Xiang , et al.
2020-06-16
Compounds As Neuronal Histamine Receptor-3 Antagonists And Uses Thereof
App 20200181112 - XIANG; JIA-NING ;   et al.
2020-06-11
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
Grant 10,618,886 - Xiang , et al.
2020-04-14
Compounds As Neuronal Histamine Receptor-3 Antagonists And Uses Thereof
App 20200102289 - XIANG; JIA-NING ;   et al.
2020-04-02
Ketamine Derivatives And Compositions Thereof
App 20190322618 - Xiang; Jia-Ning ;   et al.
2019-10-24
Catalytic conversion of bio-mass derivable aliphatic alcohols to valuable alkenes or oxygenates
Grant 10,300,464 - Lin , et al.
2019-05-28
Catalytic Conversion Of Bio-mass Derivable Aliphatic Alcohols To Valuable Alkenes Or Oxygenates
App 20150266005 - Lin; Manhua ;   et al.
2015-09-24
Radiolabeled neurokinin-1 receptor antagonists
Grant 7,354,935 - Burns , et al. April 8, 2
2008-04-08
Radiolabeled neurokinin-1 receptor antagonists
App 20050214204 - Burns, H. Donald ;   et al.
2005-09-29
Geranylgeranyl transferase inhibitor screening assay
App 20020072081 - Eng, Wai-Si ;   et al.
2002-06-13
Radiolabeled farnesyl-protein transferase inhibitors
Grant 6,060,038 - Burns , et al. May 9, 2
2000-05-09
Short synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-[C.sup.3 H.sub.3 ]-4[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide and related non radioactive compounds
Grant 5,441,722 - Eng , et al. August 15, 1
1995-08-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed